NEW YORK, Aug. 21 – Myriad Genetics’ fiscal fourth-quarter revenues climbed 17 percent to $10.8 million from $9.2 million in the fourth quarter a year ago, pushed upwards by increasing revenue from sales of the company’s diagnostic products, the company said Tuesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.